L3. Promoting rehabilitation and recovery management programmes as part of the comprehensive treatment of drug use disorders – sponsored by Chile Chair: Good Afternoon, we are tackling an L3 and L5 for an hour and half. Would like to start on a positive note, I was happy to see a consensus on scheduling in Plenary …
uk
2023 CND & CCPCJ Reconvened Session
Secretariat: Distinguished delegates, ladies and gentlemen, As many of you are aware, the term of Her Excellency Ambassador (…), who served as the chair of the CCPCJ 32nd session, concluded at the onset of this conference. On 17 November, the Secretariat received a note from the chair of the African region nominating His Excellency, the Ambassador …
CND Thematic Discussions // Session 8 – High transmission of HIV, HCV and other blood-borne diseases associated with drug use
Presenter 1, UNODC: Thank you, Mr. Chair, excellencies, ladies, and gentlemen. I will briefly discuss the lessons learned in the actual UNODC Partnership Project addressing drug use issues in Afghanistan amid the continuing humanitarian crisis. The project received funding support from the European Union for the implementation period 2023 to 2026. Addressing existing fragilities, including …
CND Thematic Discussions / Session 7 – Increase in drug-related deaths – unmet need for drug treatment and health services
Chair: Good morning, everyone. Welcome to the second part of the 2023 Thematic Discussion of the Commission on Narcotic Drugs on the implementation of all international drug policy commitments following the 2019 ministerial declaration (…) Agenda is adopted. Thank you very much. Secretariat: (organizational announcements) Director of the Division of Policy Analysis and Public Affairs …
Committee of the Whole. L.7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs
Chair: Okay, how far along are we? USA: We recommend starting on the title, we have plenty of suggestions and as this is one of the biggest outstanding issues, I hope we can make substantial progress. USA: (…) EU: We wanted to announce that we intend to co-sponsor this resolution. China: We can not go …
Committee of the Whole (Afternoon session) Resolution L.7: Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs
CHAIR: Iran, you have the floor. IRAN: I would like to congratulate you for your election to chair this important committee im confident that under your leadership we will have a great result. We previously explained that there is no room for our delegation to remove impediments, and so, under the two pragraphs, we can work on PP4, …